Hemostatic effects of low-dose protamine
โ
Miyashita, Tetsuya; Nakajima, Toshito; Hayashi, Yukio; Kuro, Masakazu
๐
Article
๐
2000
๐
John Wiley and Sons
๐
English
โ 78 KB
Twenty-eight patients undergoing cardiac surgery were prospectively studied and were assigned to two groups. The patients received 0.8-(Group L) or 2.0-fold (Group H) dose of protamine for the neutralization after cardiopulmonary bypass (CPB) which was determined by Hepcon HMSเฎพ assay system in which